Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. (Q40852256)

24 September 2017

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. (English)

1 reference

24 September 2017

1 reference

Ferry KV

1

1 reference

24 September 2017

Hamilton TC

series ordinal

2

1 reference

24 September 2017

Johnson SW

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

24 September 2017

Biochemical Pharmacology

1 reference

24 September 2017

60

1 reference

24 September 2017

1305-1313

1 reference

24 September 2017

9

1 reference

The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Nucleotide excision repair in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Repair of UV-damaged DNA by mammalian cells and Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Mutational analysis of the human nucleotide excision repair gene ERCC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Mechanism of open complex and dual incision formation by human nucleotide excision repair factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

DNA repair capacity and cisplatin sensitivity of human testis tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900441-X

10.1016/S0006-2952(00)00441-X

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference